How a rogue immune signal fuels a rare skin cancer, and how to shut it down
An international team of researchers has discovered how a molecule normally used by the immune[…]
An international team of researchers has discovered how a molecule normally used by the immune[…]
The immunoproteasome degrades cellular proteins to generate peptides, including those presented to immune system cells.[…]
IL-33 is a key cytokine in inflammation, but may also play a role in platelet[…]
Long considered a passive structural component, bone marrow adipose tissue is now emerging as a[…]
A recent discovery sheds new light on the mechanisms underlying Werner syndrome, a rare disorder[…]
The tuberculosis bacillus survives inside immune cells by neutralizing toxic metals such as zinc. A[…]
IPBS is delighted to announce the publication of groundbreaking research led by Dr. Emma Lefrançais[…]
Researchers at the Institut de Pharmacologie et Biologie Structurale (IPBS) have uncovered a pivotal role[…]
In a study published in PNAS, scientists reveal that the survival of the bacterium responsible[…]
Immunotherapy represents a true revolution in cancer treatment. With immunotherapy, some patients with previously incurable[…]